Dishman Carbogen Amcis
Dishman Carbogen Amcis, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in India. Founded in 1983, the company has established itself as a leader in contract research and manufacturing services, with a strong presence in Europe, North America, and Asia. Specialising in custom synthesis, active pharmaceutical ingredients (APIs), and drug development services, Dishman Carbogen Amcis is recognised for its innovative approach and commitment to quality. The company’s state-of-the-art facilities and expertise in complex chemistry set it apart in a competitive market. With a focus on sustainability and regulatory compliance, Dishman Carbogen Amcis has achieved significant milestones, including successful collaborations with major pharmaceutical companies. Its dedication to excellence has solidified its position as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Dishman Carbogen Amcis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dishman Carbogen Amcis's score of 29 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dishman Carbogen Amcis's reported carbon emissions
In 2024, Dishman Carbogen Amcis reported total carbon emissions of approximately 58,157,000 kg CO2e for Scope 1 and about 17,725,920 kg CO2e for Scope 2. This represents a decrease from 2023, where emissions were approximately 68,113,600 kg CO2e for Scope 1 and 15,700,600 kg CO2e for Scope 2. The company has demonstrated a commitment to reducing its carbon footprint, with a total Scope 1 and 2 emission intensity of about 5.73 kg CO2e per rupee of turnover in 2024, compared to 4.90 kg CO2e in 2023. Despite these reductions, Dishman Carbogen Amcis has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of Scope 3 emissions data indicates a potential area for future reporting and improvement. Overall, the company is actively monitoring its emissions and striving for greater sustainability in its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 48,975,800 | 00,000,000 | 00,000,000 |
| Scope 2 | 17,489,600 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dishman Carbogen Amcis is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
